Thrombotic microangiopathy (TMA) is a microvascular occlusive disorder characterised by platelet aggregation, thrombocytopenia and end-organ damage. It is commonly idiopathic, although several drug classes, including cytotoxic chemotherapy, have been implicated. Several of cases of gemcitabine-induced TMA have been documented with incidence likely to increase with the escalating use of gemcitabine. We report the cases of two patients who developed TMA while on gemcitabine chemotherapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/imj.12261 | DOI Listing |
Publication Analysis
Top Keywords
thrombotic microangiopathy
8
gemcitabine-induced thrombotic
4
microangiopathy thrombotic
4
microangiopathy tma
4
tma microvascular
4
microvascular occlusive
4
occlusive disorder
4
disorder characterised
4
characterised platelet
4
platelet aggregation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!